February 1, 2011Open Access

Development of the CLASI as a Tool to Measure Disease Severity and Responsiveness to Therapy in Cutaneous Lupus Erythematosus

Key Points

Key points are not available for this paper at this time.

Abstract

The CLASI can be used to classify patients into groups according to disease severity and to identify clinically significant improvements in disease activity.

Development of the CLASI as a Tool to Measure Disease Severity and Responsiveness to Therapy in Cutaneous Lupus Erythematosus

Key Points

Abstract

Cite This Study